{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:51Z","timestamp":1792432011475,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-025-01587-5","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:47:33Z","timestamp":1753940853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A GWAS Meta-meta-analysis and In-depth Silico Pharmacogenomic Investigations in Identification of APOE and Other Genes Associated with Pain, Anti-inflammatory, and Immunomodulating Agents in Opioid Use Disorder (OUD) Derived from 14.91 M Subjects"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8048-9587","authenticated-orcid":false,"given":"Alireza","family":"Sharafshah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4380-0166","authenticated-orcid":false,"given":"Majid","family":"Motovali-bashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-803X","authenticated-orcid":false,"given":"Kenneth","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-2914","authenticated-orcid":false,"given":"Kai-Uwe","family":"Lewandrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-8047","authenticated-orcid":false,"given":"Mark S.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1093-6051","authenticated-orcid":false,"given":"Parvaneh","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-3478","authenticated-orcid":false,"given":"Panayotis K.","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"12","key":"1587_CR2","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/brain\/awq263","volume":"133","author":"IC Anthony","year":"2010","unstructured":"Anthony IC, Norrby KE, Dingwall T, Carnie FW, Millar T, Arango JC, Robertson R, Bell JE (2010) Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers. Brain 133(12):3685\u20133698","journal-title":"Brain"},{"issue":"5","key":"1587_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00702-024-02762-6","volume":"131","author":"M Avila-Zozaya","year":"2024","unstructured":"Avila-Zozaya M, Zachariou V (2024) Genetic mouse models in opioid research: current status and future directions. J Neural Transm 131(5):491\u2013494","journal-title":"J Neural Transm"},{"issue":"3","key":"1587_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2174\/138920102003190422150527","volume":"20","author":"K Blum","year":"2019","unstructured":"Blum K, Baron D (2019) Opioid substitution therapy: achieving harm reduction while searching for a prophylactic solution. Curr Pharm Biotechnol 20(3):180\u2013182","journal-title":"Curr Pharm Biotechnol"},{"issue":"15","key":"1587_CR5","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1001\/jama.1990.03440150063027","volume":"263","author":"K Blum","year":"1990","unstructured":"Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, Cohn JB (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263(15):2055\u20132060","journal-title":"JAMA"},{"issue":"7","key":"1587_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/014107689608900711","volume":"89","author":"K Blum","year":"1996","unstructured":"Blum K, Sheridan P, Wood R, Braverman E, Chen T, Cull J, Comings D (1996) The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med 89(7):396\u2013400","journal-title":"J R Soc Med"},{"issue":"2","key":"1587_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/00325481.2015.994879","volume":"127","author":"K Blum","year":"2015","unstructured":"Blum K, Liu Y, Wang W, Wang Y, Zhang Y, Oscar-Berman M, Smolen A, Febo M, Han D, Simpatico T (2015) rsfMRI effects of KB220Z\u2122 on neural pathways in reward circuitry of abstinent genotyped heroin addicts. Postgrad Med 127(2):232\u2013241","journal-title":"Postgrad Med"},{"issue":"38","key":"1587_CR8","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2174\/1381612822666160719111346","volume":"22","author":"K Blum","year":"2016","unstructured":"Blum K, Febo M, Badgaiyan RD, Braverman ER, Dushaj K, Li M, Demetrovics Z (2016) Neuronutrient amino-acid therapy protects against reward deficiency syndrome: dopaminergic key to homeostasis and neuroplasticity. Curr Pharm Des 22(38):5837\u20135854","journal-title":"Curr Pharm Des"},{"key":"1587_CR9","doi-asserted-by":"publisher","DOI":"10.15761\/JSIN.1000229","author":"K Blum","year":"2020","unstructured":"Blum K, Lott L, Baron D, Smith DE, Badgaiyan RD, Gold MS (2020) Improving naltrexone compliance and outcomes with putative pro-dopamine regulator KB220, compared to treatment as usual. J Syst Integr Neurosci. https:\/\/doi.org\/10.15761\/JSIN.1000229","journal-title":"J Syst Integr Neurosci"},{"issue":"3","key":"1587_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/jpm11030212","volume":"11","author":"K Blum","year":"2021","unstructured":"Blum K, Kazmi S, Modestino EJ, Downs BW, Bagchi D, Baron D, McLaughlin T, Green R, Jalali R, Thanos PK (2021) A novel precision approach to overcome the \u201caddiction pandemic\u201d by incorporating genetic addiction risk severity (GARS) and dopamine homeostasis restoration. J Pers Med 11(3):212","journal-title":"J Pers Med"},{"key":"1587_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120404","volume":"442","author":"K Blum","year":"2022","unstructured":"Blum K, Bowirrat A, Gomez LL, Downs BW, Bagchi D, Barh D, Modestino EJ, Baron D, McLaughlin T, Thanos P (2022a) Why haven\u2019t we solved the addiction crisis? J Neurol Sci 442:120404","journal-title":"J Neurol Sci"},{"issue":"6","key":"1587_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/jpm12061009","volume":"12","author":"K Blum","year":"2022","unstructured":"Blum K, Brodie MS, Pandey SC, Cadet JL, Gupta A, Elman I, Thanos PK, Gondre-Lewis MC, Baron D, Kazmi S (2022b) Researching mitigation of alcohol binge drinking in polydrug abuse: KCNK13 and RASGRF2 gene (s) risk polymorphisms coupled with genetic addiction risk severity (GARS) guiding precision pro-dopamine regulation. J Pers Med 12(6):1009","journal-title":"J Pers Med"},{"issue":"2","key":"1587_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/jpm12020321","volume":"12","author":"K Blum","year":"2022","unstructured":"Blum K, McLaughlin T, Bowirrat A, Modestino EJ, Baron D, Gomez LL, Ceccanti M, Braverman ER, Thanos PK, Cadet JL (2022c) Reward deficiency syndrome (RDS) surprisingly is evolutionary and found everywhere: is it \u201cblowin\u2019in the wind\u201d? J Pers Med 12(2):321","journal-title":"J Pers Med"},{"issue":"2","key":"1587_CR14","first-page":"1","volume":"9","author":"K Blum","year":"2023","unstructured":"Blum K, Bowirrat A, Braverman ER, Dennen C, Zeine F, Jafari N, Sunder K, Thanos PK, Baron D, Barh D (2023a) Beyond Mor: can induction of dopamine homeostasis along with electrotherapy attenuate the opioid crisis? Clin Exp Psychol 9(2):1","journal-title":"Clin Exp Psychol"},{"key":"1587_CR15","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v11i8.4211","author":"K Blum","year":"2023","unstructured":"Blum K, Gold MS, Cadet JL, Gondre-Lewis MC, McLaughlin T, Braverman ER, Elman I, Carney BP, Cortese R, Abijo T (2023b) Invited expert opinion-bioinformatic and limitation directives to help adopt genetic addiction risk screening and identify preaddictive reward dysregulation: required analytic evidence to induce dopamine homeostatsis. Med Res Arch. https:\/\/doi.org\/10.18103\/mra.v11i8.4211","journal-title":"Med Res Arch"},{"issue":"1","key":"1587_CR16","first-page":"1","volume":"8","author":"K Blum","year":"2024","unstructured":"Blum K, Baron D, McLaughlin T, Thanos PK, Dennen C, Ceccanti M, Braverman ER, Sharafshah A, Lewandrowski K-U, Giordano J (2024) Summary document research on RDS anti-addiction modeling: annotated bibliography. J Addict Psychiatry 8(1):1","journal-title":"J Addict Psychiatry"},{"key":"1587_CR17","doi-asserted-by":"crossref","unstructured":"Br\u00fcggemann P, Rajguru K (2022) Comprehensive meta-analysis (CMA) 3.0: a software review. Springer","DOI":"10.1057\/s41270-022-00184-5"},{"issue":"6","key":"1587_CR18","first-page":"499","volume":"19","author":"L Cao","year":"2002","unstructured":"Cao L, Li T, Xu K, Liu X (2002) Association study of heroin-dependence and-287 A\/G polymorphism of catechol-O-methyltransferase gene. Zhonghua yi xue yi Chuan xue za zhi 19(6):499\u2013501","journal-title":"Zhonghua yi xue yi Chuan xue za zhi"},{"key":"1587_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109478","volume":"236","author":"PO Coffin","year":"2022","unstructured":"Coffin PO, Maya S, Kahn JG (2022) Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin. Drug Alcohol Depend 236:109478","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1587_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.clpt.2006.09.011","volume":"80","author":"JK Coller","year":"2006","unstructured":"Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA (2006) ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals. Clin Pharmacol Ther 80(6):682\u2013690","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1587_CR21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00001756-199904060-00042","volume":"10","author":"DE Comings","year":"1999","unstructured":"Comings DE, Blake H, Dietz G, Gade-Andavolu R, Legro RS, Saucier G, Johnson P, Verde R, MacMurray JP (1999) The proenkephalin gene (PENK) and opioid dependence. NeuroReport 10(5):1133\u20131135","journal-title":"NeuroReport"},{"issue":"20","key":"1587_CR22","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.1073\/pnas.0600871103","volume":"103","author":"K Drakenberg","year":"2006","unstructured":"Drakenberg K, Nikoshkov A, Horv\u00e1th MC, Fagergren P, Gharibyan A, Saarelainen K, Rahman S, Nylander I, Bakalkin G, Rajs J (2006) \u03bc Opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proc Natl Acad Sci 103(20):7883\u20137888","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"1587_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2741\/4509","volume":"22","author":"M Febo","year":"2017","unstructured":"Febo M, Blum K, Badgaiyan RD, Baron D, Thanos PK, Colon-Perez LM, Demortrovics Z, Gold MS (2017a) Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. Front Biosci (Landmark Ed) 22(4):669\u2013691","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"4","key":"1587_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174774","volume":"12","author":"M Febo","year":"2017","unstructured":"Febo M, Blum K, Badgaiyan RD, Perez PD, Colon-Perez LM, Thanos PK, Ferris CF, Kulkarni P, Giordano J, Baron D (2017b) Enhanced functional connectivity and volume between cognitive and reward centers of na\u00efve rodent brain produced by pro-dopaminergic agent KB220Z. PLoS ONE 12(4):e0174774","journal-title":"PLoS ONE"},{"issue":"6","key":"1587_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2174\/1389201021666191210112108","volume":"21","author":"L Fried","year":"2020","unstructured":"Fried L, Modestino EJ, Siwicki D, Lott L, Thanos PK, Baron D, Badgaiyan RD, Ponce JV, Giordano J, Downs WB (2020) Hypodopaminergia and \u201cPrecision Behavioral Management\u201d (PBM): it is a generational family affair. Curr Pharm Biotechnol 21(6):528\u2013541","journal-title":"Curr Pharm Biotechnol"},{"key":"1587_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1023\/A:1019883806620","volume":"36","author":"A Galeeva","year":"2002","unstructured":"Galeeva A, Gareeva A, Yur\u2019ev E, Khusnutdinova E (2002) VNTR polymorphisms of the serotonin transporter and dopamine transporter genes in male opiate addicts. Mol Biol 36:462\u2013466","journal-title":"Mol Biol"},{"issue":"3","key":"1587_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/geno.1998.5454","volume":"52","author":"J Gelernter","year":"1998","unstructured":"Gelernter J, Kranzler H, Lacobelle J (1998) Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), \u03bc opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). Genomics 52(3):289\u2013297","journal-title":"Genomics"},{"issue":"6","key":"1587_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ajmg.b.30510","volume":"144","author":"G Gerra","year":"2007","unstructured":"Gerra G, Leonardi C, Cortese E, D\u2019Amore A, Lucchini A, Strepparola G, Serio G, Farina G, Magnelli F, Zaimovic A (2007) Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am J Med Genet B 144(6):771\u2013775","journal-title":"Am J Med Genet B"},{"issue":"1","key":"1587_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/1389201024666230427111117","volume":"25","author":"ED Gilley","year":"2024","unstructured":"Gilley ED, Bowirrat A, Gupta A, Giordano J, Dennen CA, Braverman E, Badgaiyan RD, McLaughlin T, Baron D, Blum K (2024) The future is now for precision genomic addiction medicine as a frontline modality for inducing \u201cDopamine Homeostasis\u201d in reward deficiency syndrome (RDS). Curr Pharm Biotechnol 25(1):42\u201357","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"1587_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/00952990.2020.1780602","volume":"46","author":"VL Gregory Jr","year":"2020","unstructured":"Gregory VL Jr, Ellis RJB (2020) Cognitive-behavioral therapy and buprenorphine for opioid use disorder: a systematic review and meta-analysis of randomized controlled trials. Am J Drug Alcohol Abuse 46(5):520\u2013530","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"1587_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1017\/S0033291723003057","volume":"54","author":"LJ Hannigan","year":"2024","unstructured":"Hannigan LJ, Lund IO, Askelund AD, Ystrom E, Corfield EC, Ask H, Havdahl A (2024) Genotype\u2013environment interplay in associations between maternal drinking and offspring emotional and behavioral problems. Psychol Med 54(1):203\u2013214","journal-title":"Psychol Med"},{"issue":"5","key":"1587_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/1096-8628(20001009)96:5<599::AID-AJMG4>3.0.CO;2-O","volume":"96","author":"R Horowitz","year":"2000","unstructured":"Horowitz R, Kotler M, Shufman E, Aharoni S, Kremer I, Cohen H, Ebstein RP (2000) Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am J Med Genet 96(5):599\u2013603","journal-title":"Am J Med Genet"},{"issue":"2","key":"1587_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/npp.2008.37","volume":"34","author":"W Huang","year":"2009","unstructured":"Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N, Li MD (2009) Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology 34(2):319\u2013330","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1587_CR34","first-page":"98","volume":"70","author":"N Hula","year":"1998","unstructured":"Hula N, Marhitych V, Hovseieva N, Klimashevs\u2019 ky\u012d V, Zhukov O, Synyts\u2019 ky\u012d V (1998) Brain lipid composition of the rat with experimental morphine dependence. Ukrainskii Biokhimicheskii Zhurnal 70(2):98\u2013105","journal-title":"Ukrainskii Biokhimicheskii Zhurnal"},{"issue":"1","key":"1587_CR35","doi-asserted-by":"publisher","first-page":"12058","DOI":"10.1038\/s41598-021-91533-4","volume":"11","author":"M Kazemi","year":"2021","unstructured":"Kazemi M, Bazyar M, Naghizadeh MM, Dehghan A, Rahimabadi MS, Chijan MR, Bijani M, Zahmatkeshan M, Ghaemi A, Samimi N (2021) Lipid profile dysregulation in opium users based on Fasa PERSIAN cohort study results. Sci Rep 11(1):12058","journal-title":"Sci Rep"},{"issue":"8","key":"1587_CR36","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1017\/S0033291723003641","volume":"54","author":"KS Kendler","year":"2024","unstructured":"Kendler KS, L\u00f6nn SL, Sundquist J, Sundquist K (2024) The joint effects of genetic liability and the death of close relatives on risk for major depression and alcohol use disorder in a Swedish national sample. Psychol Med 54(8):1709\u20131716","journal-title":"Psychol Med"},{"issue":"1","key":"1587_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1213\/01.ane.0000266490.64814.ff","volume":"105","author":"WA Kofke","year":"2007","unstructured":"Kofke WA, Blissitt PA, Rao H, Wang J, Addya K, Detre J (2007) Remifentanil-induced cerebral blood flow effects in normal humans: dose and ApoE genotype. Anesth Analg 105(1):167\u2013175","journal-title":"Anesth Analg"},{"issue":"5","key":"1587_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/1096-8628(20001009)96:5<592::AID-AJMG3>3.0.CO;2-Y","volume":"96","author":"BR Lawford","year":"2000","unstructured":"Lawford BR, Young RM, Noble EP, Sargent J, Rowell J, Shadforth S, Zhang X, Ritchie T (2000) The D2 dopamine receptor A1 allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet 96(5):592\u2013598","journal-title":"Am J Med Genet"},{"issue":"3","key":"1587_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/jpm15030103","volume":"15","author":"K-U Lewandrowski","year":"2025","unstructured":"Lewandrowski K-U, Blum K, Sharafshah A, Thanos KZ, Thanos PK, Zirath R, Pinhasov A, Bowirrat A, Jafari N, Zeine F (2025) Genetic and regulatory mechanisms of comorbidity of anxiety, depression and ADHD: a GWAS meta-meta-analysis through the lens of a system biological and pharmacogenomic perspective in 18.5 M subjects. J Pers Med 15(3):103","journal-title":"J Pers Med"},{"issue":"3","key":"1587_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ajmg.b.30264","volume":"141","author":"Y Li","year":"2006","unstructured":"Li Y, Shao C, Zhang D, Zhao M, Lin L, Yan P, Xie Y, Jiang K, Jin L (2006) The effect of dopamine D2, D5 receptor and transporter (SLC6A3) polymorphisms on the cue-elicited heroin craving in Chinese. Am J Med Genet B 141(3):269\u2013273","journal-title":"Am J Med Genet B"},{"issue":"1","key":"1587_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0040002","volume":"4","author":"C-Y Li","year":"2008","unstructured":"Li C-Y, Mao X, Wei L (2008) Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 4(1):e2","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"1587_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/ADM.0b013e318262a9a1","volume":"6","author":"S-H Lin","year":"2012","unstructured":"Lin S-H, Yang YK, Lee S-Y, Hsieh PC, Chen PS, Lu R-B, Chen KC (2012) Association between cholesterol plasma levels and craving among heroin users. J Addict Med 6(4):287\u2013291","journal-title":"J Addict Med"},{"issue":"1","key":"1587_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13062-023-00444-z","volume":"18","author":"S Liu","year":"2023","unstructured":"Liu S, Yang S, Zhu X, Li X, Zhang X, Zhou X, Cheng H, Huo F-Q, Mao Q, Liang L (2023) Spinal apolipoprotein E is involved in inflammatory pain via regulating lipid metabolism and glial activation in the spinal dorsal horn. Biol Direct 18(1):85","journal-title":"Biol Direct"},{"issue":"4","key":"1587_CR44","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/00000542-200210000-00011","volume":"97","author":"J L\u00f6tsch","year":"2002","unstructured":"L\u00f6tsch J, Zimmermann M, Darimont J, Marx C, Dudziak R, Skarke C, Geisslinger G (2002) Does the A118G polymorphism at the \u03bc-opioid receptor gene protect against morphine-6-glucuronide toxicity? J Am Soc Anesthesiol 97(4):814\u2013819","journal-title":"J Am Soc Anesthesiol"},{"key":"1587_CR45","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2165\/00003088-200443140-00003","volume":"43","author":"J L\u00f6tsch","year":"2004","unstructured":"L\u00f6tsch J, Skarke C, Liefhold J, Geisslinger G (2004) Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives. Clin Pharmacokinet 43:983\u20131013","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"1587_CR46","doi-asserted-by":"publisher","first-page":"e18943","DOI":"10.1016\/j.heliyon.2023.e18943","volume":"9","author":"MT Makale","year":"2023","unstructured":"Makale MT, Abbasi S, Nybo C, Keifer J, Christman L, Fairchild JK, Yesavage J, Blum K, Gold MS, Baron D (2023a) Personalized repetitive transcranial magnetic stimulation (PRTMS\u00ae) for post-traumatic stress disorder (PTSD) in military combat veterans. Heliyon 9(8):e18943","journal-title":"Heliyon"},{"issue":"8","key":"1587_CR47","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/brainsci13081179","volume":"13","author":"MT Makale","year":"2023","unstructured":"Makale MT, Nybo C, Keifer J, Blum K, Dennen CA, Baron D, Sunder K, Elman I, Makale MR, Thanos PK (2023b) Preliminary observations of personalized repetitive magnetic stimulation (PrTMS) guided by EEG spectra for concussion. Brain Sci 13(8):1179","journal-title":"Brain Sci"},{"issue":"25","key":"1587_CR48","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1523\/JNEUROSCI.0062-05.2005","volume":"25","author":"CA McClung","year":"2005","unstructured":"McClung CA, Nestler EJ, Zachariou V (2005) Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J Neurosci 25(25):6005\u20136015","journal-title":"J Neurosci"},{"issue":"3","key":"1587_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.gheart.2017.03.002","volume":"12","author":"A Murphy","year":"2017","unstructured":"Murphy A, Faria-Neto JR, Al-Rasadi K, Blom D, Catapano A, Cuevas A, Lopez-Jimenez F, Perel P, Santos R, Sniderman A (2017a) World Heart Federation cholesterol roadmap. Glob Heart 12(3):179\u2013197. e175","journal-title":"Glob Heart"},{"issue":"8","key":"1587_CR51","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1017\/S0033291723003732","volume":"54","author":"PJ Na","year":"2024","unstructured":"Na PJ, Deak JD, Kranzler HR, Pietrzak RH, Gelernter J (2024) Genetic and non-genetic predictors of risk for opioid dependence. Psychol Med 54(8):1779\u20131786","journal-title":"Psychol Med"},{"key":"1587_CR1","doi-asserted-by":"publisher","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2020) Repositioning of the global epicentre of non-optimal cholesterol. Nature 582(7810):73\u201377. https:\/\/doi.org\/10.1038\/s41586-020-2338-1","DOI":"10.1038\/s41586-020-2338-1"},{"issue":"3","key":"1587_CR52","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/00952990.2011.563335","volume":"37","author":"ZJ Pereska","year":"2011","unstructured":"Pereska ZJ, Bozinovska C, Dimitrovski C, Petkovska L, Cibisev A, Jurukov I (2011) Plasma apo\/lipoproteins disturbances as a precondition for metabolic syndrome in HCV seronegative heroin addicts. Am J Drug Alcohol Abuse 37(3):196\u2013202","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1587_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12640-014-9497-5","volume":"27","author":"A Sadakierska-Chudy","year":"2015","unstructured":"Sadakierska-Chudy A, Kostrzewa RM, Filip M (2015) A comprehensive view of the epigenetic landscape part I: DNA methylation, passive and active DNA demethylation pathways and histone variants. Neurotox Res 27:84\u201397","journal-title":"Neurotox Res"},{"issue":"9","key":"1587_CR54","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1176\/ajp.128.9.1132","volume":"128","author":"MA Schuckit","year":"1972","unstructured":"Schuckit MA, Goodwin DA, Winokur G (1972) A study of alcoholism in half siblings. Am J Psychiatry 128(9):1132\u20131136","journal-title":"Am J Psychiatry"},{"issue":"5","key":"1587_CR55","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/rej.2011.1169","volume":"14","author":"D Seripa","year":"2011","unstructured":"Seripa D, D\u2019Onofrio G, Panza F, Cascavilla L, Masullo C, Pilotto A (2011) The genetics of the human APOE polymorphism. Rejuvenation Res 14(5):491\u2013500","journal-title":"Rejuvenation Res"},{"issue":"1","key":"1587_CR56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10571-024-01504-2","volume":"44","author":"A Sharafshah","year":"2024","unstructured":"Sharafshah A, Motovali-Bashi M, Keshavarz P, Blum K (2024) Synergistic epistasis and systems biology approaches to uncover a pharmacogenomic map linked to pain, anti-inflammatory and immunomodulating agents (PAIma) in a healthy cohort. Cell Mol Neurobiol 44(1):74","journal-title":"Cell Mol Neurobiol"},{"key":"1587_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/jne.70033","author":"P Sinclair","year":"2025","unstructured":"Sinclair P, Dhanjal NS, Towers EB, Lynch WJ, Kabbani N (2025) Proteomic analysis of plasma proteins during fentanyl withdrawal in ovariectomized female rats with and without estradiol. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.70033","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"1587_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.nbd.2006.02.005","volume":"23","author":"J Turchan-Cholewo","year":"2006","unstructured":"Turchan-Cholewo J, Liu Y, Gartner S, Reid R, Jie C, Peng X, Chen KCC, Chauhan A, Haughey N, Cutler R (2006) Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Neurobiol Dis 23(1):109\u2013119","journal-title":"Neurobiol Dis"},{"issue":"5","key":"1587_CR59","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/jrsm.1654","volume":"14","author":"RC van Aert","year":"2023","unstructured":"van Aert RC (2023) Meta-analyzing partial correlation coefficients using Fisher\u2019s z transformation. Res Synth Methods 14(5):768\u2013773","journal-title":"Res Synth Methods"},{"issue":"8","key":"1587_CR60","first-page":"584","volume":"50","author":"H Wilczek","year":"2004","unstructured":"Wilczek H, Ceska R, Zlatohlavek L (2004) Serum lipids in drug addicts. Vnitr Lek 50(8):584\u2013586","journal-title":"Vnitr Lek"},{"issue":"3","key":"1587_CR61","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.mehy.2003.10.013","volume":"62","author":"PB Wood","year":"2004","unstructured":"Wood PB (2004) Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Med Hypotheses 62(3):420\u2013424","journal-title":"Med Hypotheses"},{"issue":"6","key":"1587_CR62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archpsyc.61.6.597","volume":"61","author":"K Xu","year":"2004","unstructured":"Xu K, Lichtermann D, Lipsky RH, Franke P, Liu X, Hu Y, Cao L, Schwab SG, Wildenauer DB, Bau CH (2004) Association of specific haplotypes of D2 dopamine receptorgene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 61(6):597\u2013606","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"1587_CR63","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4172\/1522-4821.1000111","volume":"16","author":"F Zeine","year":"2014","unstructured":"Zeine F (2014) Awareness integration: a new therapeutic model. Int J Emerg Ment Health 16(2):278\u2013283","journal-title":"Int J Emerg Ment Health"},{"issue":"10","key":"1587_CR64","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1097\/j.pain.0000000000000634","volume":"157","author":"M Zunhammer","year":"2016","unstructured":"Zunhammer M, Schweizer LM, Witte V, Harris RE, Bingel U, Schmidt-Wilcke T (2016) Combined glutamate and glutamine levels in pain-processing brain regions are associated with individual pain sensitivity. Pain 157(10):2248\u20132256","journal-title":"Pain"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-025-01587-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:03:04Z","timestamp":1765537384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-025-01587-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1007\/s10571-025-01587-5","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Kenneth Blum reports royalties from and discloses many pending USA and foreign patents on GARS and KB220 variants licensed to Synaptamine and Victory Nutrition International. The authors report no other conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}],"article-number":"76"}}